# US 2020/0002677 A1 · Method for inducing trans-differentiation of cardiomyocytes based on exosome

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002677 A1
- Document ID: US20200002677A1
- Status: Published application
- Kind: A1
- Application number: 16/456,127
- Filed: 2019-06-28
- Published: 2020-01-02
- Earliest claimed: 2018-06-28
- Assignees: Korea Institute of Science and Technology
- Applicants: Korea Institute of Science and Technology
- Inventors: Ick Chan KWON; Sun Hwa KIM; Yoosoo YANG; Hyosuk KIM
- Web page: https://patentgrep.com/patent/US20200002677A1

## CPC

- C12N 5/0657: {Cardiomyocytes; Heart cells}
- C12N 2500/30: Organic components
- C12N 2500/32: Amino acids
- C12N 2500/38: Vitamins
- C12N 2501/235: Leukemia inhibitory factor [LIF]
- C12N 2501/33: Insulin
- C12N 2506/02: from embryonic cells
- C12N 2506/1307: from adult fibroblasts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method for inducing trans-differentiation of cardiomyocytes based on exosome, and more particularly, to a method for inducing trans-differentiation of a fibroblast into a cardiomyocyte, comprising the steps of: isolating exosomes in a culture medium during a process of differentiating a stem cell into the cardiomyocyte; culturing a fibroblast in a cardiomyocyte reprogramming medium containing the isolated exosomes; and culturing the fibroblast cultured in a cardiomyocyte differentiation medium containing the isolated exosomes.

## Claims

### Claim 1

A method of inducing trans-differentiation a fibroblast to a cardiomyocyte, the method comprising:
isolating exosomes in a culture medium during a process of differentiating a stem cell into the cardiomyocyte;
culturing a fibroblast in a cardiomyocyte reprogramming medium containing the isolated exosomes; and
culturing the fibroblast cultured in a cardiomyocyte differentiation medium containing the isolated exosomes.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the exosomes are prepared by mixing a first exosome isolated during a mesoderm induction process and a second exosome isolated during a cardiac specification and maturation process.

### Claim 3 (depends on 2)

The method according to claim 2, wherein mixing ratio of the first exosome and the second exosome is from 1:19 to 19:1.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the cardiomyocyte reprogramming medium comprises 2 to 7 wt % of KnockOut Serum Replacement, 10 to 17 wt % of embryonic stem cell fetal calf serum (ES-FBS), 0.1 to 2 wt % of N2, 1 to 3 wt % of B-27, 0.5 to 2 wt % of Glutamax, 0.5 to 2 wt % of nonessential amino acid (NEAA), 0.05 to 0.2 mM of β-mercaptoethanol, and 20 to 70 μg/ml of ascorbic acid.

### Claim 5 (depends on 1)

The method according to claim 1, the cardiomyocyte differentiation medium comprises 12 to 20 wt % of fetal bovine serum, 20 to 70 μg/ml of ascorbic acid, 0.5 to 2 μg/ml of insulin, and 500 to 1,500 units/ml of leukemia inhibitory factor actor.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the cardiomyocyte differentiation medium further comprises a chemical agent for inducing cardiomyocyte differentiation.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the chemical agent is one or a mixture of two or more selected from the group consisting of CHIR99021, PD0325901, SB431542, Tranylcypromine, Forskolin, Repsox, TTNPB, and Valproic Acid (VPA).

### Claim 8 (depends on 7)

The method according to claim 7, wherein the chemical agent is added to the cardiomyocyte differentiation medium at a concentration of 1 to 50 μM.

### Claim 9

A method for trans-differentiating a fibroblast into a cardiomyocyte, comprising:
isolating exosomes in a culture medium during a process of differentiating stem cells into cardiomyocytes;
culturing the fibroblast in a cardiomyocyte reprogramming medium containing the isolated exosomes; and
culturing the fibroblast in a cardiomyocyte differentiation medium containing the isolated exosomes and a chemical agent for inducing cardiomyocyte differentiation.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the exosomes are prepared by mixing a first exosome isolated during a mesoderm induction process and a second exosome isolated during a cardiac specification and maturation process.

### Claim 11

A composition for inducing trans-differentiation of a fibroblast into a cardiomyocyte comprising exosomes isolated from stem cells and a chemical agent for inducing cardiomyocyte differentiation.

### Claim 12 (depends on 11)

The composition according to claim 11, wherein the exosomes are prepared by mixing a first exosome isolated during a mesoderm induction process and a second exosome isolated during a cardiac specification and maturation process.

### Claim 13 (depends on 11)

The composition according to claim 11, wherein the chemical agent is one or a mixture of two or more selected from the group consisting of CHIR99021, PD0325901, SB431542, Tranylcypromine, Forskolin, Repsox, TTNPB, and Valproic Acid (VPA).
